Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT

A. Sureda, S.G. Stavrik, A. Boumendil, H. Finel, I. Khvedelidze, S. Dietricht, P. Dreger, O. Hermine, C. Kyriakou, S. Robinson, N. Schmitz, H.C. Schouten, A. Tanase, S. Montoto

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2170-2179
Number of pages10
JournalBone Marrow Transplantation
Volume55
Issue number11
DOIs
Publication statusPublished - 1 Nov 2020

Keywords

  • blood progenitor-cell
  • bone-marrow-transplantation
  • brentuximab vedotin
  • european group
  • haploidentical transplantation
  • high-dose chemotherapy
  • posttransplantation cyclophosphamide
  • prognostic-factors
  • reduced-intensity
  • versus-host-disease
  • BLOOD PROGENITOR-CELL
  • PROGNOSTIC-FACTORS
  • BONE-MARROW-TRANSPLANTATION
  • BRENTUXIMAB VEDOTIN
  • EUROPEAN GROUP
  • VERSUS-HOST-DISEASE
  • REDUCED-INTENSITY
  • POSTTRANSPLANTATION CYCLOPHOSPHAMIDE
  • HAPLOIDENTICAL TRANSPLANTATION
  • HIGH-DOSE CHEMOTHERAPY

Cite this